CRISPR Therapeutics AG - Common Shares (NQ:CRSP)

55.82 -0.64 (-1.14%)

Streaming Delayed Price Updated: 9:48 AM EST, Dec 24, 2025 Add to My Watchlist

Price and Volume

Volume	94,753
Open	56.45
Bid (Size)	55.76 (200)
Ask (Size)	55.87 (200)
Prev. Close	56.46
Today's Range	55.21 - 56.55
52wk Range	30.04 - 78.48
Shares Outstanding	78,935,098
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Is CRISPR Therapeutics Stock Yesterday's News? ↗

Today 4:35 EST

The biotech sells blood disorders treatment, Casgevy.

Via The Motley Fool

3 Brilliant Growth Stocks to Buy Now and Hold for the Long Term ↗

December 23, 2025

All three companies' businesses are on the verge of long-term growth explosions.

Via The Motley Fool

Performance

YTD	+34.7%	+34.7%
1 Month	+8.9%	+8.9%
3 Month	-8.1%	-8.1%
6 Month	+19.3%	+19.3%
1 Year	+37.9%	+37.9%

More News

Is CRISPR Therapeutics a Buy, Sell, or Hold in 2026? ↗

December 19, 2025

Via The Motley Fool

2 Growth Stocks to Invest $1,000 in Right Now ↗

December 18, 2025

Via The Motley Fool

Retail Bulls Call CRISPR ‘Criminally Undervalued’ After Gene-Editing Breakthrough Cuts Cholesterol By 70% ↗

November 10, 2025

Via Stocktwits

From Insulin Injections to Functional Cures: Regenerative Medicine Reshapes Diabetes

December 16, 2025

From USA News Group

Via GlobeNewswire

2 Monster Stocks in the Making to Buy and Hold ↗

December 16, 2025

Via The Motley Fool

12 Days of Investing: My Top 12 Stocks to Buy Before 2026 ↗

December 15, 2025

Via The Motley Fool

2 Healthcare Stocks to Buy Ahead of the New Year ↗

December 12, 2025

Via The Motley Fool

2 Stocks That Could Soar by 52% and 282%, According to Wall Street ↗

December 07, 2025

Via The Motley Fool

Meet the Beaten-Down Biotech Stock Cathie Wood Loves That Wall Street Says May Soar 50% ↗

November 30, 2025

Via The Motley Fool

The Best Stocks to Buy With $1,000 Right Now ↗

November 29, 2025

Via The Motley Fool

3 Mid-Cap Growth Stocks That Have Mammoth Long-Term Potential ↗

November 21, 2025

Via The Motley Fool

Agios Pharmaceuticals Plunges Over 50% as Sickle Cell Drug Delivers Mixed Phase 3 Results

November 19, 2025

Via MarketMinute

Missed Out on Eli Lilly? 2 Healthcare Stocks With Big Catalysts on the Horizon. ↗

November 19, 2025

Via The Motley Fool

1 Underrated Stock That Could Soar by 58%, According to Wall Street ↗

November 17, 2025

Via The Motley Fool

The Tech Tsunami: How Breakthroughs in AI, Quantum, and Green Energy Are Reshaping the Stock Market

November 14, 2025

Via MarketMinute

ARK Sold Almost 400,000 Shares of CRISPR Therapeutics. Is Cathie Wood Worried? ↗

November 12, 2025

Via The Motley Fool

CRISPR Therapeutics' Investigational Gene Therapy Shows Promising Lipid-Lowering Effects In Early Trial ↗

November 11, 2025

Via Benzinga

Why Gene-Editing Giants Crispr And Intellia Just Surged ↗

November 10, 2025

Via Investor's Business Daily

Intellia Therapeutics Crashes After A Patient In Its Pivotal Study Dies ↗

November 07, 2025

Via Investor's Business Daily

AI Unlocks Gene-Editing Revolution: $2 Million Grant Propels Disease Cures

November 06, 2025

Via TokenRing AI

Cathie Wood Goes All-In On Peter Thiel's Crypto Play Bullish With Back-To-Back Million-Dollar Buys ↗

November 04, 2025

Via Benzinga

AI Unleashes a New Era in Cell and Gene Therapy: A Quarter Century Update Reveals Transformative Potential

November 04, 2025

Via TokenRing AI

Prediction: 2 Stocks That Will Be Worth More Than SoundHound AI 2 Years From Now ↗

November 04, 2025

Via The Motley Fool

Frequently Asked Questions

Is CRISPR Therapeutics AG - Common Shares publicly traded?

Yes, CRISPR Therapeutics AG - Common Shares is publicly traded.

What exchange does CRISPR Therapeutics AG - Common Shares trade on?

CRISPR Therapeutics AG - Common Shares trades on the Nasdaq Stock Market

What is the ticker symbol for CRISPR Therapeutics AG - Common Shares?

The ticker symbol for CRISPR Therapeutics AG - Common Shares is CRSP on the Nasdaq Stock Market

What is the current price of CRISPR Therapeutics AG - Common Shares?

The current price of CRISPR Therapeutics AG - Common Shares is 55.82

When was CRISPR Therapeutics AG - Common Shares last traded?

The last trade of CRISPR Therapeutics AG - Common Shares was at 12/24/25 09:48 AM ET

What is the market capitalization of CRISPR Therapeutics AG - Common Shares?

The market capitalization of CRISPR Therapeutics AG - Common Shares is 4.41B

How many shares of CRISPR Therapeutics AG - Common Shares are outstanding?

CRISPR Therapeutics AG - Common Shares has 4B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.